AORTIC PSEUDOANEURYSM

AORTIC PSEUDOANEURYSM was reported 59 times

AORTIC PSEUDOANEURYSM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 2 0.0011
1 Bispecific CD20-directed CD3 T Cell Engager [EPC] 2 0.0005
2 Human Immunoglobulin G [EPC] 6 0.0003
3 Antimetabolite Immunosuppressant [EPC] 6 0.0003
4 Autologous Cellular Immunotherapy [EPC] 1 0.0002
5 Penem Antibacterial [EPC] 3 0.0001
6 Glycopeptide Antibacterial [EPC] 5 0.0001
7 Interleukin-6 Receptor Antagonist [EPC] 10 0.0001
8 Oxazolidinone Antibacterial [EPC] 2 0.0001
9 Purine Antimetabolite [EPC] 6 0.0001
10 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
11 Folate Analog Metabolic Inhibitor [EPC] 15 0.0000
12 Alkylating Drug [EPC] 7 0.0000
13 Rifamycin Antibacterial [EPC] 1 0.0000
14 Azole Antifungal [EPC] 3 0.0000
15 Antirheumatic Agent [EPC] 2 0.0000
16 Factor Xa Inhibitor [EPC] 5 0.0000
17 Complement Inhibitor [EPC] 1 0.0000
18 Antidote [EPC] 1 0.0000
19 Tumor Necrosis Factor Blocker [EPC] 14 0.0000
20 Androgen Receptor Inhibitor [EPC] 1 0.0000
21 Corticosteroid [EPC] 17 0.0000
22 Platelet Aggregation Inhibitor [EPC] 7 0.0000
23 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
24 Acetylcholine Release Inhibitor [EPC] 1 0.0000
25 Kinase Inhibitor [EPC] 5 0.0000
26 Fluoroquinolone Antibacterial [EPC] 1 0.0000
27 Prostacycline Vasodilator [EPC] 1 0.0000
28 Janus Kinase Inhibitor [EPC] 1 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 7 0.0000
30 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
31 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
32 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
33 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
34 Proton Pump Inhibitor [EPC] 1 0.0000